GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Short-Term Debt

CurveBeam AI (ASX:CVB) Short-Term Debt : A$1.02 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI Short-Term Debt?

CurveBeam AI's Short-Term Debt for the quarter that ended in Dec. 2023 was A$1.02 Mil.

CurveBeam AI's quarterly Short-Term Debt increased from Jun. 2022 (A$0.00 Mil) to Jun. 2023 (A$1.07 Mil) but then declined from Jun. 2023 (A$1.07 Mil) to Dec. 2023 (A$1.02 Mil).

CurveBeam AI's annual Short-Term Debt stayed the same from Jun. 2021 (A$0.00 Mil) to Jun. 2022 (A$0.00 Mil) but then increased from Jun. 2022 (A$0.00 Mil) to Jun. 2023 (A$1.07 Mil).


CurveBeam AI Short-Term Debt Historical Data

The historical data trend for CurveBeam AI's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI Short-Term Debt Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23
Short-Term Debt
- - 1.07

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23
Short-Term Debt - - - 1.07 1.02

CurveBeam AI Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


CurveBeam AI Short-Term Debt Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


CurveBeam AI (ASX:CVB) Business Description

Traded in Other Exchanges
N/A
Address
10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines